Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1972 1
1998 1
2000 2
2001 3
2002 1
2003 8
2004 4
2007 2
2013 1
2014 2
2015 4
2016 5
2017 1
2019 4
2020 2
2021 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics.
Davda J, Declerck P, Hu-Lieskovan S, Hickling TP, Jacobs IA, Chou J, Salek-Ardakani S, Kraynov E. Davda J, et al. Among authors: jacobs ia. J Immunother Cancer. 2019 Apr 15;7(1):105. doi: 10.1186/s40425-019-0586-0. J Immunother Cancer. 2019. PMID: 30992085 Free PMC article. Review.
Assessing the Immunogenicity of Biopharmaceuticals.
Pineda C, Castañeda Hernández G, Jacobs IA, Alvarez DF, Carini C. Pineda C, et al. Among authors: jacobs ia. BioDrugs. 2016 Jun;30(3):195-206. doi: 10.1007/s40259-016-0174-5. BioDrugs. 2016. PMID: 27097915 Free PMC article. Review.
Considerations in the early development of biosimilar products.
Li EC, Abbas R, Jacobs IA, Yin D. Li EC, et al. Among authors: jacobs ia. Drug Discov Today. 2015 May;20 Suppl 2:1-9. doi: 10.1016/j.drudis.2014.12.017. Epub 2015 Jan 6. Drug Discov Today. 2015. PMID: 25572407 Review.
Key considerations in the preclinical development of biosimilars.
Bui LA, Hurst S, Finch GL, Ingram B, Jacobs IA, Kirchhoff CF, Ng CK, Ryan AM. Bui LA, et al. Among authors: jacobs ia. Drug Discov Today. 2015 May;20 Suppl 1:3-15. doi: 10.1016/j.drudis.2015.03.011. Epub 2015 Apr 23. Drug Discov Today. 2015. PMID: 25912284 Review.
Statistical Primer on Biosimilar Clinical Development.
Isakov L, Jin B, Jacobs IA. Isakov L, et al. Among authors: jacobs ia. Am J Ther. 2016 Nov/Dec;23(6):e1903-e1910. doi: 10.1097/MJT.0000000000000391. Am J Ther. 2016. PMID: 26766293 Free PMC article. Review.
Biosimilars and cancer treatment of older patients.
Lichtman SM, Reske T, Jacobs IA. Lichtman SM, et al. Among authors: jacobs ia. J Geriatr Oncol. 2016 Mar;7(1 Suppl):S1-8. doi: 10.1016/j.jgo.2016.01.002. Epub 2016 Feb 5. J Geriatr Oncol. 2016. PMID: 26856525 Free article.
44 results